Medication-Naïve Blood Pressure and Incident Cancers: Analysis of 2 Nationwide Population-Based Databases.
Hidehiro KanekoYuichiro YanoHyeok-Hee LeeHokyou LeeAkira OkadaHidetaka ItohKojiro MoritaAkira FukuiKatsuhito FujiuYuta SuzukiSatoshi MatsuokaSunao NakamuraNobuaki MichihataTaisuke JoNorifumi TakedaHiroyuki MoritaTakashi YokooAkira NishiyamaKoichi NodeAnthony J VieraPaul MuntnerSuzanne OparilHyeon Chang KimHideo YasunagaIssei KomuroPublished in: American journal of hypertension (2022)
Medication-naïve BP was associated with higher incidences of thyroid, esophageal, colorectal, liver, and kidney cancers. Uncovering the underlying mechanisms for our results may help identify novel therapeutic approach for hypertension and cancer.
Keyphrases
- blood pressure
- papillary thyroid
- hypertensive patients
- adverse drug
- healthcare
- childhood cancer
- heart rate
- cardiovascular disease
- squamous cell
- big data
- emergency department
- lymph node metastasis
- squamous cell carcinoma
- cross sectional
- metabolic syndrome
- blood glucose
- adipose tissue
- machine learning
- insulin resistance
- artificial intelligence
- arterial hypertension